Status:
UNKNOWN
Skeletal Muscle Dysfunction in Heart Failure
Lead Sponsor:
Ullevaal University Hospital
Collaborating Sponsors:
Norwegian Health Association
Norwegian School of Sport Sciences
Conditions:
Heart Failure, Congestive
Eligibility:
All Genders
40-78 years
Phase:
NA
Brief Summary
Patients suffering from congestive heart failure report reduced exercise capacity. This skeletal muscle dysfunction is also detectable when using small muscle groups which should not put any demand on...
Eligibility Criteria
Inclusion
- Coronary Heart Failure
- Ejection fraction \<35%
- NYHA 2-3
- Spirometry FEV1 \> 80%
Exclusion
- Cardiomyopathy
- Transplantation candidate
- Active malignancy
- Restraining skeletal-muscular disease
- Claudication in legs
- Hospitalized last 30 days due to acute ischemic episode
- Intravenous inotrope or vasodilatating drugs last 14 days prior to inclusion
- AMI last 8 weeks prior to inclusion
- Organized training last 4 months
- Smoking on daily basis last 4 months
- Creatinin \< 150microliters/liter
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00156234
Start Date
March 1 2005
Last Update
September 12 2005
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Experimental Medical Research
Oslo, Oslo County, Norway, 0407
2
Norwegian School of Sport Sciences
Oslo, Oslo County, Norway, 0806